Recombinant multi-species GALNT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GALNT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. Transcript variants derived from this gene that utilize alternative polyA signals have been described in the literature. [provided by RefSeq, Jul 2008]
The Alternative Names of target: GALNAC-T1,GALNT1,Galnt1,Polypeptide GalNAc transferase 1 (GalNAc-T1,Polypeptide N-acetylgalactosaminyltransferase 1,Protein-UDP acetylgalactosaminyltransferase 1,UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1,galNAc-T1,pp-GaNTase 1)

Target products collectionGo to GALNT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0233-Ag-1/ GM-Tg-hg-SE0233-Ag-2 Human GALNT1 protein Human
GM-Tg-rg-SE0233-Ag-1/ GM-Tg-rg-SE0233-Ag-2 Rat GALNT1 protein Rat
GM-Tg-mg-SE0233-Ag-1/ GM-Tg-mg-SE0233-Ag-2 Mouse GALNT1 protein Mouse
GM-Tg-cynog-SE0233-Ag-1/ GM-Tg-cynog-SE0233-Ag-2 Cynomolgus/Rhesus macaque GALNT1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0233-Ag-1/ GM-Tg-felg-SE0233-Ag-2 Feline GALNT1 protein Feline
GM-Tg-cang-SE0233-Ag-1/ GM-Tg-cang-SE0233-Ag-2 Canine GALNT1 protein Canine
GM-Tg-bovg-SE0233-Ag-1/ GM-Tg-bovg-SE0233-Ag-2 Bovine GALNT1 protein Bovine
GM-Tg-equg-SE0233-Ag-1/ GM-Tg-equg-SE0233-Ag-2 Equine GALNT1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0233-Ag-1/ GM-Tg-hg-SE0233-Ag-2; GM-Tg-rg-SE0233-Ag-1/ GM-Tg-rg-SE0233-Ag-2;
GM-Tg-mg-SE0233-Ag-1/ GM-Tg-mg-SE0233-Ag-2; GM-Tg-cynog-SE0233-Ag-1/ GM-Tg-cynog-SE0233-Ag-2;
GM-Tg-felg-SE0233-Ag-1/ GM-Tg-felg-SE0233-Ag-2; GM-Tg-cang-SE0233-Ag-1/ GM-Tg-cang-SE0233-Ag-2;
GM-Tg-bovg-SE0233-Ag-1/ GM-Tg-bovg-SE0233-Ag-2; GM-Tg-equg-SE0233-Ag-1/ GM-Tg-equg-SE0233-Ag-2
Products Name GALNT1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GALNT1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GALNT1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.